| | | Idaho, the below articles on Trop2 expression in different cancers is the path to silly:
Ovarian cancer
onlinelibrary.wiley.com
Gastric cancer
ncbi.nlm.nih.gov
Colorectal cancer
clincancerres.aacrjournals.org
Pancreatic cancer
nature.com
Finally, let’s all do ourselves a favor and study this article below in excruciating detail. And please also read the name of the principal author of the study. Spoiler alert: David M Goldenberg.
ncbi.nlm.nih.gov
“As mentioned, with rare exceptions, has been linked to increased tumor growth and enhanced proliferation ... and is overexpressed in most human solid epithelial cancers, such as oral, head-and-neck, thyroid, lung, esophageal, gastric, colorectal, pancreatic, breast, renal, uterine, cervical, ovarian cancers, and glioma [ 37– 50]. These authors proposed that TROP-2 is a prognostic marker in most of these cancers.”
PS: The most tinfoil hats among you are likely thinking I’m actually Cynthia A. Sullivan, and to you I say light another bowl. |
|
